C000104621 Performance — NYLI VP Candriam Emerging Markets Equity Portfolio, Initial Class
Data updated: 2026-08-24
C000104621 returned +30.64% year to date and +56.68% over one year to Jun 2026. Annualised returns are +27.14% over 3 years and +6.25% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $206, against $179 for the category, and to $157 over one year, against $141. Volatility over the past three years was 17.56% a year. In the 12 months to Jun 2026 the fund lost a net $67.9M, and assets reached $234.75M.
C000104621 Growth of $100
What $100 invested in NYLI VP Candriam Emerging Markets Equity Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | C000104621 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $157 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $206 | $179 |
| 5 years (Jul 2021 – Jun 2026) | $135 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $203 | $195 |
C000104621 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +30.64% |
| 1 year | +56.68% |
| 3 years (annualised) | +27.14% |
| 5 years (annualised) | +6.25% |
C000104621 Annual Returns
Calendar-year total returns of NYLI VP Candriam Emerging Markets Equity Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +30.64% |
| 2025 | +35.90% |
| 2024 | +12.65% |
| 2023 | +7.24% |
| 2022 | −28.71% |
| 2021 | −1.99% |
| 2020 | +25.73% |
| 2019 (Jul–Dec) | +8.01% |
C000104621 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +11.5% | +4.7% | −9.9% | +15.8% | +7.7% | −0.4% | — | — | — | — | — | — |
| 2025 | +1.1% | −0.6% | +0.3% | +0.4% | +3.9% | +7.8% | +1.0% | +4.4% | +8.8% | +3.8% | −2.2% | +3.0% |
| 2024 | −4.5% | +6.1% | +2.7% | +0.6% | +1.8% | +4.3% | −1.2% | +1.0% | +6.1% | −2.6% | −2.2% | +0.4% |
| 2023 | +9.3% | −7.7% | +3.7% | −2.4% | −1.8% | +4.0% | +6.0% | −5.5% | −3.6% | −3.8% | +7.8% | +2.6% |
| 2022 | −2.0% | −4.3% | −1.5% | −8.8% | +0.7% | −7.4% | −1.9% | −1.1% | −10.8% | −1.1% | +10.7% | −4.2% |
| 2021 | +3.6% | +1.9% | −1.4% | +3.4% | +0.8% | +1.9% | −5.4% | +1.4% | −5.6% | +1.6% | −4.9% | +1.2% |
| 2020 | −4.5% | −4.0% | −16.2% | +10.5% | +2.5% | +8.1% | +10.1% | +2.6% | −2.1% | +2.8% | +9.0% | +8.1% |
| 2019 | — | — | — | — | — | — | −1.2% | −3.3% | +1.2% | +3.7% | −0.1% | +7.9% |
C000104621 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 17.56%
- 3-year Sharpe ratio: 1.29 (vs 4.5% risk-free rate)
- Best month: +15.85% (Apr 2026)
- Worst month: −9.85% (Mar 2026)
C000104621 Fund Flows
Monthly money in and out of NYLI VP Candriam Emerging Markets Equity Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$67.9M
- 12-month gross sales (incl. reinvestments): $1.9M
- Sales ÷ redemptions: 0.03×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $216K | $4.0M | −$3.7M |
| May 2026 | $147K | $12.8M | −$12.7M |
| Apr 2026 | $81K | $3.3M | −$3.2M |
| Mar 2026 | $66K | $3.5M | −$3.4M |
| Feb 2026 | $60K | $4.6M | −$4.5M |
| Jan 2026 | $32K | $5.5M | −$5.5M |
| Dec 2025 | $431K | $2.4M | −$1.9M |
| Nov 2025 | $47K | $7.6M | −$7.6M |
| Oct 2025 | $643K | $13.0M | −$12.4M |
| Sep 2025 | $53K | $2.1M | −$2.1M |
| Aug 2025 | $38K | $7.2M | −$7.1M |
| Jul 2025 | $70K | $3.8M | −$3.7M |
C000104621 Assets Under Management
Net assets of NYLI VP Candriam Emerging Markets Equity Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $234.75M |
| 2026-03-31 | $205.39M |
| 2025-12-31 | $207.59M |
| 2025-09-30 | $220.59M |
| 2025-06-30 | $204.85M |
| 2025-03-31 | $191.87M |
| 2024-12-31 | $206.02M |
| 2024-09-30 | $225.34M |
| 2024-06-30 | $221.74M |
| 2024-03-31 | $221.99M |
| 2023-12-31 | $220.33M |
| 2023-09-30 | $210.78M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.